Pulse Biosciences, Inc.’s Post

View organization page for Pulse Biosciences, Inc., graphic

8,047 followers

From surgical to catheter-based therapies, our Nanosecond Pulsed Field Ablation (nsPFA™) platform is designed to provide a foundation for diverse therapeutic applications. Why does this matter? Our architecture isn’t just flexible – it's proven. With over 6,000 patients already treated across various disciplines, discover how nsPFA™ technology has the potential to set new standards for patient care across the anatomy: https://lnkd.in/ecqttCuR Indications for Use: The CellFX Percutaneous Electrode System is FDA Cleared for use in the US and intended for ablation of soft tissue in percutaneous, and intraoperative surgical procedures. The CellFX System is also intended for dermatological procedures requiring ablation and resurfacing of the skin. #nsPFA #MedTech #Innovation

To view or add a comment, sign in

Explore topics